Biotech · Private company
Addex Pharma S.A.
Track this companyFree. Adds Addex Pharma S.A. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- DipraglurantPhase 3 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DipraglurantPhase 2 · BlepharospasmClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based TherapyPHASE2_PHASE3 · TERMINATED · started Oct 25, 2021ClinicalTrials.gov NCT05116813 · fetched Nov 12, 2026
- Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With BlepharospasmPHASE2 · COMPLETED · started Oct 6, 2021ClinicalTrials.gov NCT05027997 · fetched Nov 12, 2026
- Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based TherapyPHASE2_PHASE3 · TERMINATED · started Aug 6, 2021ClinicalTrials.gov NCT04857359 · fetched Nov 12, 2026